Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank38
3Y CAGR-7.8%
5Y CAGR-10.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-7.8%/yr
vs +13.1%/yr prior
5Y CAGR
-10.6%/yr
Consistent
Acceleration
-20.9pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $70.50M | +47.1% |
| 2024 | $47.92M | -26.3% |
| 2023 | $65.06M | -27.7% |
| 2022 | $90.03M | -35.3% |
| 2021 | $139.06M | +12.7% |
| 2020 | $123.44M | +27.8% |
| 2019 | $96.58M | +75.5% |
| 2018 | $55.03M | -35.5% |
| 2017 | $85.31M | - |